207 related articles for article (PubMed ID: 27885282)
1. Genome-wide association studies of drug response and toxicity: an opportunity for genome medicine.
Giacomini KM; Yee SW; Mushiroda T; Weinshilboum RM; Ratain MJ; Kubo M
Nat Rev Drug Discov; 2017 Jan; 16(1):1. PubMed ID: 27885282
[No Abstract] [Full Text] [Related]
2. Genomic technology applied to pharmacological traits.
Yang JJ; Plenge RM
JAMA; 2011 Aug; 306(6):652-3. PubMed ID: 21828330
[No Abstract] [Full Text] [Related]
3. Pharmacogenomic genome-wide association studies: lessons learned thus far.
Crowley JJ; Sullivan PF; McLeod HL
Pharmacogenomics; 2009 Feb; 10(2):161-3. PubMed ID: 19207016
[No Abstract] [Full Text] [Related]
4. Genome-wide association study: a useful tool to identify common genetic variants associated with drug toxicity and efficacy in cancer pharmacogenomics.
Low SK; Takahashi A; Mushiroda T; Kubo M
Clin Cancer Res; 2014 May; 20(10):2541-52. PubMed ID: 24831277
[TBL] [Abstract][Full Text] [Related]
5. Whole-genome sequencing in pharmacogenetics.
Urban TJ
Pharmacogenomics; 2013 Mar; 14(4):345-8. PubMed ID: 23438878
[No Abstract] [Full Text] [Related]
6. Using genome-wide association studies to identify genes important in serious adverse drug reactions.
Daly AK
Annu Rev Pharmacol Toxicol; 2012; 52():21-35. PubMed ID: 21819236
[TBL] [Abstract][Full Text] [Related]
7. HLA: a pharmacogenomics success story.
Becquemont L
Pharmacogenomics; 2010 Mar; 11(3):277-81. PubMed ID: 20235781
[No Abstract] [Full Text] [Related]
8. Pharmacogenomics arrives.
Petsko GA
Genome Biol; 2004; 5(6):108. PubMed ID: 15186481
[TBL] [Abstract][Full Text] [Related]
9. Progress in understanding the genomic basis for adverse drug reactions: a comprehensive review and focus on the role of ethnicity.
Chan SL; Jin S; Loh M; Brunham LR
Pharmacogenomics; 2015; 16(10):1161-78. PubMed ID: 25978008
[TBL] [Abstract][Full Text] [Related]
10. Pharmacogenomics: historical perspective and current status.
Charlab R; Zhang L
Methods Mol Biol; 2013; 1015():3-22. PubMed ID: 23824846
[TBL] [Abstract][Full Text] [Related]
11. Genetics and variable drug response.
Wilke RA; Dolan ME
JAMA; 2011 Jul; 306(3):306-7. PubMed ID: 21771992
[No Abstract] [Full Text] [Related]
12. An update on the pharmacogenetics of treating hypertension.
Fontana V; Luizon MR; Sandrim VC
J Hum Hypertens; 2015 May; 29(5):283-91. PubMed ID: 25355012
[TBL] [Abstract][Full Text] [Related]
13. Improving vaccine safety through a better understanding of vaccine adverse events.
Pasternak B; Feenstra B; Melbye M; Hviid A
Clin Infect Dis; 2015 May; 60(10):1586-7. PubMed ID: 25648238
[No Abstract] [Full Text] [Related]
14. Pharmacogenomics and drug toxicity.
Nakamura Y
N Engl J Med; 2008 Aug; 359(8):856-8. PubMed ID: 18650508
[No Abstract] [Full Text] [Related]
15. Pharmacogenetics: The right drug for you.
Drew L
Nature; 2016 Sep; 537(7619):S60-2. PubMed ID: 27602742
[No Abstract] [Full Text] [Related]
16. Pharmacogenomics of adverse drug reactions: practical applications and perspectives.
Becquemont L
Pharmacogenomics; 2009 Jun; 10(6):961-9. PubMed ID: 19530963
[TBL] [Abstract][Full Text] [Related]
17. Molecular diagnostics as a predictive tool: genetics of drug efficacy and toxicity.
Johnson JA; Evans WE
Trends Mol Med; 2002 Jun; 8(6):300-5. PubMed ID: 12067617
[TBL] [Abstract][Full Text] [Related]
18. Stevens-Johnson syndrome and toxic epidermal necrolysis: an update on pharmacogenetics studies in drug-induced severe skin reaction.
Rufini S; Ciccacci C; Politi C; Giardina E; Novelli G; Borgiani P
Pharmacogenomics; 2015 Nov; 16(17):1989-2002. PubMed ID: 26555663
[TBL] [Abstract][Full Text] [Related]
19. Insights from genome-wide association studies of drug response.
Zhou K; Pearson ER
Annu Rev Pharmacol Toxicol; 2013; 53():299-310. PubMed ID: 23072379
[TBL] [Abstract][Full Text] [Related]
20. [Pharmacogenetics and prediction of side effects of drugs].
Harrak M; Khabbal Y; Amarti A; El Hassouni M; Ouldim K
Ann Biol Clin (Paris); 2014; 72(4):405-12. PubMed ID: 25119798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
